Dr. Christopher Stephen Pastor, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Houston St, Beeville, TX 78102 Phone: 361-354-2041 |
News Archive
Ironwood Pharmaceuticals, Inc. and Depomed, Inc. today announced that Ironwood has licensed worldwide rights to utilize Depomed's Acuform gastric retentive drug delivery technology for an Ironwood early stage development program, continuing Ironwood's efforts to augment its development pipeline beyond linaclotide.
A protein critical in heart development may also play a part in colon cancer progression. Research led by investigators from Vanderbilt-Ingram Cancer Center and the Vanderbilt Eye Institute suggests that the protein BVES (blood vessel endocardial substance) - which also is key in regulating corneal cells - may be a therapeutic target for halting colon cancer metastasis.
The Associated Press reports that the overhaul's definition of "American Indian" only includes those tribes that are recognized by the federal government, though more than 100 tribes are recognized by state governments but not that U.S. Bureau of Indian Affairs. Other outlets report on insurance rates under the ACA, doctor-owned hospitals and the much lamented "doc fix" in Congress.
Scientists at the Wellcome Sanger Institute have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.
MacroMedics BV the innovation leader in patient fixation devices has signed a distribution contract with Xstrahl in the USA. Xstrahl have been successfully distributing MacroMedics in the UK for 3 years. This partnership has allowed radiotherapy centers across the UK to gain access to the innovative and versatile systems. Now Xstrahl will be offering these unique products to US hospitals.
› Verified 9 days ago